Windtree Therapeutics (WINT) has a debt-to-equity ratio of 374.89, above the Healthcare sector average of 0.28.
Get informed when a big investor buys or sells
+ Follow374.89
Debt-to-Equity ratio measures a company's financial leverage by comparing its total debt to shareholder equity. A lower D/E ratio generally indicates a more financially stable company with less risk.
As of the most recent data, WINT shows a debt-to-equity ratio of 374.89. That is above the Healthcare sector average of 0.28. Scroll down for historical charts and peer comparison views.
The Healthcare sector average debt-to-equity ratio is about 0.28. Windtree Therapeutics is at 374.89, which is higher that average. That is roughly 135473.8% above the sector mean. Use the comparison chart on this page to see how WINT stacks up against individual peers as well.
Investors watch WINT's debt-to-equity ratio because it compresses price and fundamentals into one number that is easy to compare across companies and over time. Windtree Therapeutics's latest reading is 374.89. Combining that with growth, ROE, and debt metrics usually beats relying on a single multiple.
Besides this debt-to-equity ratio page, Stockcircle has Windtree Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect debt-to-equity ratio (currently 374.89) with ownership activity and broader fundamentals.
The Healthcare average debt-to-equity ratio is about 0.28, while WINT is at 374.89. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.